Multidrug-Resistant Bacteria Isolated from Blood Culture Samples in a Moroccan Tertiary Hospital: True Bacteremia or Contamination?
Soumia Nachate,Salma Rouhi,Hicham Ouassif,Hind Bennani,Abdelhamid Hachimi,Youssef Mouaffak,Said Younous,Fatiha Bennaoui,Nadia El Idrissi Slitine,Fadl Mrabih Rabou Maoulainine,Asmae Lamrani Hanchi,Nabila Soraa
DOI: https://doi.org/10.2147/IDR.S373065
2022-09-28
Infection and Drug Resistance
Abstract:Soumia Nachate, 1 Salma Rouhi, 1 Hicham Ouassif, 1 Hind Bennani, 1 Abdelhamid Hachimi, 2 Youssef Mouaffak, 3 Said Younous, 3 Fatiha Bennaoui, 4 Nadia El Idrissi Slitine, 4 Fadl Mrabih Rabou Maoulainine, 4 Asmae Lamrani Hanchi, 1 Nabila Soraa 1 1 Department of Microbiology, Mohamed VI University Hospital Center, Marrakech, Morocco; 2 Department of Intensive Care, Mohamed VI University Hospital Center, Marrakech, Morocco; 3 Pediatric Intensive Care Department, Mohamed VI University Hospital Center, Marrakech, Morocco; 4 Neonatal Intensive Care Department, Mohamed VI University Hospital Center, Marrakech, Morocco Correspondence: Soumia Nachate, Department of Microbiology, Mohamed VI University Hospital Center, BP2360 Principal, Ibn Sina Avenue, Marrakech, 40160, Morocco, Tel +212 658956312, Email Purpose: To demonstrate the relevance of clinico-biological correlation in the interpretation of positive blood cultures (BC) for multidrug-resistant (MDR) bacteria, among adult and pediatric patients, in order to distinguish between true bacteremia (TB) and contaminations and to evaluate the impact on patient management. Patients and Methods: This six-month study was conducted at Mohammed VI University Hospital in Marrakech. All MDR bacteria isolated from BCs carried out on hospitalized patients during this period were included. For each positive BC to MDR microorganism, demographic and clinical characteristics, laboratory findings, therapeutic and evolution data were collected. Results: TB was considered in 157 (94.6%) of the 166 positive-culture episodes for MDR bacteria, while 9 (5.4%) were classified as false-positive. Contamination rate was 0.2% (9/3824). TB and contaminations occurred mainly in intensive care units (ICUs), with the neonatal ICU being the most concerned (p = 0.016). Clinical signs of sepsis were present in all TB patients, with a significant difference between the two groups (p = 0.000). CRP values were higher in the TB group (p = 0.000). The most isolated true pathogens were ESBL-producing Enterobacterales (50%) and carbapenem-resistant Enterobacterales (33.3%). They also predominated in contaminated BCs. Isolation of the same microorganism from other sites was significantly associated with TB (p = 0.012). In contrast to the contaminations group, the difference in the clinical course of TB patients, according to whether or not they received appropriate probabilistic antibiotics, was statistically significant (p = 0.000). These patients had longer hospital stays and longer durations of antibiotic therapy. The overall mortality rate was 39.6%. Conclusion: Distinguishing between MDR-positive BCs representing clinically significant bacteremia or simple contamination requires a careful clinical, biological, and microbiological confrontation of each MDR positive BC in order to avoid unnecessary overuse of broad-spectrum antibiotics and thus reduce resistance selective pressure. Keywords: blood culture, multidrug-resistant bacteria, clinico-biological correlation, true bacteremia, contamination According to the World Health Organisation (WHO), antimicrobial resistance is currently the most urgent threat to global health. 1 It contributes to an estimated 700,000 deaths per year and is expected to cause 10 million deaths per year by 2050 if no effective interventions are adopted. 2 Multidrug-resistant (MDR) bacteria carry an arsenal of virulence factors and have acquired versatile resistance mechanisms to counteract the most effective antibiotics. 3 Among MDR bacteria, the following pathogens: Enterococcus (E.) faecium, Staphylococcus (S.) aureus, Klebsiella pneumoniae, Acinetobacter (A.) baumannii, Pseudomonas (P.) aeruginosa, and Enterobacter species have been designated under the acronym "ESKAPE" because of their ability to escape the bactericidal activity of conventional antibiotics. 4 In February 2017, the WHO developed a priority pathogen list where ESKAPEs and other microorganisms were stratified into three categories according to the urgency of the need for new antibiotics: critical, high, and medium priority. Vancomycin-resistant Enterococcus (VRE) faecium and methicillin-resistant Staphylococcus aureus (MRSA) were classified as high priority pathogens. Carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Pseudomonas aeruginosa (CRPA), and carbapenem-producing or extended-spectrum beta-lactamase (ESBL)-producing strains of Enterobacterales were stratified as critical priority pathogens as they cause life-threate -Abstract Truncated-
pharmacology & pharmacy,infectious diseases